FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Omeprazole from Sandoz Inc, granting approval for this generic proton pump inhibitor under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)